by
Brendon Nafziger, DOTmed News Associate Editor | January 10, 2011
Hologic Inc. said Friday it bought Interlace Medical Inc., a manufacturer of a device for removing uterine fibroids, for $125 million in cash.
The deal also includes two annual cash-contingent payments, based on revenue growth from the prior year.
"The acquisition of Interlace is consistent with our strategy to strengthen our leadership position in women's health care," Steve Williamson, Hologic's senior vice president and general manager of OB/GYN surgical products said in a statement.
Ad Statistics
Times Displayed: 78308
Times Visited: 2782 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Privately held Interlace, headquartered in Framingham, Mass., makes MyoSure, a minimally invasive system that removes fibroids and polyps. Nearly 5 million women in the United States suffer from fibroids or polyps that can be treated with the system, Hologic said.
Bedford, Mass.-based Hologic said it's rolling out doctor training and education programs and plans on fully promoting the product early this year.
